Table 4 |
|||||
|
Diagnostics performance of CK19 and Galectin-3 in the distinction of PTC from benign thyroid lesions |
|||||
|
SN |
SP |
FNR |
FPR |
DAC |
|
|
|
|||||
|
CK19 |
96.37% |
74.17% |
3.63% |
25.83% |
90.71% |
|
Galectin-3 |
96.82% |
49.01% |
3.18% |
50.99% |
84.63% |
|
|
|||||
|
SN; Sensitivity; SP: specificity; FNR: False negative rate; FPR: False positive rate; DAC: diagnostic accuracy |
|||||
|
Song et al. Diagnostic Pathology 2011 6:126 doi:10.1186/1746-1596-6-126 |
|||||